JP2013525355A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525355A5 JP2013525355A5 JP2013506202A JP2013506202A JP2013525355A5 JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5 JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- optionally substituted
- alkyl
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims description 98
- 238000000034 method Methods 0.000 claims description 68
- 125000005843 halogen group Chemical group 0.000 claims description 41
- 125000000217 alkyl group Chemical group 0.000 claims description 32
- 125000003545 alkoxy group Chemical group 0.000 claims description 25
- 125000001931 aliphatic group Chemical group 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 239000007818 Grignard reagent Substances 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- 150000004795 grignard reagents Chemical class 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 5
- 230000002140 halogenating effect Effects 0.000 claims description 5
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 4
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- LVKCSZQWLOVUGB-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].C[CH-]C LVKCSZQWLOVUGB-UHFFFAOYSA-M 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 0 C*CC(O1)=C(N)OC1=O Chemical compound C*CC(O1)=C(N)OC1=O 0.000 description 81
- 239000001301 oxygen Substances 0.000 description 5
- DXSTXHWCNNXUIA-UHFFFAOYSA-N IN1CCSCC1 Chemical compound IN1CCSCC1 DXSTXHWCNNXUIA-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N c1ccncc1 Chemical compound c1ccncc1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- JGYHLKLMZWAYKN-UHFFFAOYSA-N CCc(cc1)cnc1C(CCl)=O Chemical compound CCc(cc1)cnc1C(CCl)=O JGYHLKLMZWAYKN-UHFFFAOYSA-N 0.000 description 3
- VWQYWKZKOVZIHE-UHFFFAOYSA-O C1C[NH2+]CSCC1 Chemical compound C1C[NH2+]CSCC1 VWQYWKZKOVZIHE-UHFFFAOYSA-O 0.000 description 2
- IMYCCGJUZBTONO-UHFFFAOYSA-N C=NN1CCCCC1 Chemical compound C=NN1CCCCC1 IMYCCGJUZBTONO-UHFFFAOYSA-N 0.000 description 2
- BXVAVXHPXVAUBU-UHFFFAOYSA-N CC(C)N1CCCCCC1 Chemical compound CC(C)N1CCCCCC1 BXVAVXHPXVAUBU-UHFFFAOYSA-N 0.000 description 2
- MFEIKQPHQINPRI-UHFFFAOYSA-N CCc1cccnc1 Chemical compound CCc1cccnc1 MFEIKQPHQINPRI-UHFFFAOYSA-N 0.000 description 2
- AVFZOVWCLRSYKC-UHFFFAOYSA-N CN1CCCC1 Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 2
- ZKUKXSWKWGHYKJ-UHFFFAOYSA-N CN1CCCCCC1 Chemical compound CN1CCCCCC1 ZKUKXSWKWGHYKJ-UHFFFAOYSA-N 0.000 description 2
- YPIYCXORPTWOIL-UHFFFAOYSA-N C[IH]N(c1c2cccc1)NN2O Chemical compound C[IH]N(c1c2cccc1)NN2O YPIYCXORPTWOIL-UHFFFAOYSA-N 0.000 description 2
- GWWMVGUEIDAXCB-UHFFFAOYSA-N C[N](C)(Nc1c2cccc1)N2O Chemical compound C[N](C)(Nc1c2cccc1)N2O GWWMVGUEIDAXCB-UHFFFAOYSA-N 0.000 description 2
- WIFJIKIOKWYURB-UHFFFAOYSA-N C[N]1(C)CCOCCC1 Chemical compound C[N]1(C)CCOCCC1 WIFJIKIOKWYURB-UHFFFAOYSA-N 0.000 description 2
- GAUKKFMRLMOULV-UHFFFAOYSA-N IN1CCCCC1 Chemical compound IN1CCCCC1 GAUKKFMRLMOULV-UHFFFAOYSA-N 0.000 description 2
- SPGPGBWICPNRSN-UHFFFAOYSA-N I[n]1cncc1 Chemical compound I[n]1cncc1 SPGPGBWICPNRSN-UHFFFAOYSA-N 0.000 description 2
- ZMMMAYLQQKMTBL-UHFFFAOYSA-N Oc1ccc(C=C2C=CC=C2)cc1 Chemical compound Oc1ccc(C=C2C=CC=C2)cc1 ZMMMAYLQQKMTBL-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- QJEYNOFYGNLVFE-UHFFFAOYSA-O C=C(C(Cc(cc1)ccc1O)C([OH2+])=N1)C1=O Chemical compound C=C(C(Cc(cc1)ccc1O)C([OH2+])=N1)C1=O QJEYNOFYGNLVFE-UHFFFAOYSA-O 0.000 description 1
- WPOQSCFRWAQPKI-UHFFFAOYSA-N CC(N(C(C(Cc(cc1)ccc1O)S1)=O)C1=O)=O Chemical compound CC(N(C(C(Cc(cc1)ccc1O)S1)=O)C1=O)=O WPOQSCFRWAQPKI-UHFFFAOYSA-N 0.000 description 1
- HSPXULVKHRXNQE-UHFFFAOYSA-N CCC(N(C(C(Cc(cc1)ccc1O)S1)=O)C1=O)=O Chemical compound CCC(N(C(C(Cc(cc1)ccc1O)S1)=O)C1=O)=O HSPXULVKHRXNQE-UHFFFAOYSA-N 0.000 description 1
- PDUYDKDSVCFLEV-UHFFFAOYSA-N CC[IH]N1CCOCC1 Chemical compound CC[IH]N1CCOCC1 PDUYDKDSVCFLEV-UHFFFAOYSA-N 0.000 description 1
- JMNFLHLUKPBOQV-UHFFFAOYSA-N COCC(O1)=C(N)OC1=O Chemical compound COCC(O1)=C(N)OC1=O JMNFLHLUKPBOQV-UHFFFAOYSA-N 0.000 description 1
- RGHHSNMVTDWUBI-UHFFFAOYSA-N Oc1ccc(C=O)cc1 Chemical compound Oc1ccc(C=O)cc1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 1
- CUJIDZLHNDCTQL-UHFFFAOYSA-N Oc1ccc(CC(C(N2C(Oc3ccccc3)=O)=O)SC2=O)cc1 Chemical compound Oc1ccc(CC(C(N2C(Oc3ccccc3)=O)=O)SC2=O)cc1 CUJIDZLHNDCTQL-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- -1 methoxy, ethoxy Chemical group 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32550210P | 2010-04-19 | 2010-04-19 | |
| US61/325,502 | 2010-04-19 | ||
| US32749810P | 2010-04-23 | 2010-04-23 | |
| US61/327,498 | 2010-04-23 | ||
| PCT/US2011/032822 WO2011133442A1 (en) | 2010-04-19 | 2011-04-18 | Novel synthesis for thiazolidinedione compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525355A JP2013525355A (ja) | 2013-06-20 |
| JP2013525355A5 true JP2013525355A5 (cg-RX-API-DMAC7.html) | 2014-04-24 |
Family
ID=44148625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013506202A Pending JP2013525355A (ja) | 2010-04-19 | 2011-04-18 | チアゾリジンジオン化合物の新規合成 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8937182B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2560956B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013525355A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101781665B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102947269B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011242956B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2796437C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2560956T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2610623T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE030263T2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2012012092A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ602883A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2560956T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2012148908A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011133442A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8592427B2 (en) * | 2010-06-24 | 2013-11-26 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| RU2594725C2 (ru) | 2010-08-10 | 2016-08-20 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Синтез соединений тиазолидиндиона |
| EP2603498B1 (en) * | 2010-08-10 | 2016-11-09 | Octeta Therapeutics, LLC | Novel synthesis for thiazolidinedione compounds |
| US12084472B2 (en) | 2015-12-18 | 2024-09-10 | Ardelyx, Inc. | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
| TWI773657B (zh) | 2015-12-18 | 2022-08-11 | 美商亞德利克斯公司 | 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物 |
| US20210038566A1 (en) | 2018-02-08 | 2021-02-11 | Enyo Pharma | Use of modulators of neet proteins for the treatment of infection |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US5143930A (en) | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| EP0579733B1 (en) * | 1991-04-11 | 2001-06-20 | PHARMACIA & UPJOHN COMPANY | Thiazolidinedione derivatives, production and use thereof |
| NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| JPH07188227A (ja) * | 1993-12-24 | 1995-07-25 | Japan Tobacco Inc | チアゾリジン誘導体及びオキサゾール誘導体 |
| SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | Astra Ab | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| AP869A (en) * | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
| US7407978B2 (en) | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| FR2817144B1 (fr) | 2000-11-29 | 2003-01-03 | Micro Mega Sa | Sequence d'instruments canalaires pour l'execution d'un protocole operatoire d'endodontie |
| WO2003029251A1 (en) * | 2001-09-28 | 2003-04-10 | Biocon Limited | Novel process for the synthesis of thiazolidinedione derivatives |
| FR2861069B1 (fr) | 2003-10-17 | 2005-12-09 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| NZ571872A (en) | 2006-03-16 | 2011-05-27 | Metabolic Solutions Dev Co | Combination therapies of thiazolidinedione analogues and glucocorticoid agonists |
| CN101454006B (zh) | 2006-03-16 | 2012-12-26 | 新陈代谢解决方案开发公司 | 用于治疗高血压以及用于降低血脂的噻唑烷二酮类似物 |
| ES2654908T3 (es) | 2006-03-16 | 2018-02-15 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona para el tratamiento de enfermedades mediadas por una inflamación metabólica |
| US8367708B2 (en) * | 2006-12-01 | 2013-02-05 | Msd K.K. | Phenyl-isoxazol-3-ol derivative |
| WO2008118327A1 (en) * | 2007-03-23 | 2008-10-02 | University Of Toledo | Conformationally restrained epothilone analogues as anti-leukemic agents |
| JP5371988B2 (ja) | 2007-09-14 | 2013-12-18 | メタボリック ソリューションズ ディベロップメント カンパニー， エルエルシー | 高血圧を処置するためのチアゾリジンジオン類似体 |
| WO2009148195A1 (en) * | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same |
| MX2012012094A (es) | 2010-04-19 | 2012-12-17 | Metabolic Solutions Dev Co Llc | Sintesis novedosa para compuestos de tiazolidinadiona. |
| RU2594725C2 (ru) | 2010-08-10 | 2016-08-20 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Синтез соединений тиазолидиндиона |
| EP2603498B1 (en) | 2010-08-10 | 2016-11-09 | Octeta Therapeutics, LLC | Novel synthesis for thiazolidinedione compounds |
-
2011
- 2011-04-18 HU HUE11716155A patent/HUE030263T2/en unknown
- 2011-04-18 US US13/641,917 patent/US8937182B2/en active Active
- 2011-04-18 CN CN201180030253.8A patent/CN102947269B/zh not_active Expired - Fee Related
- 2011-04-18 DK DK11716155.4T patent/DK2560956T3/en active
- 2011-04-18 AU AU2011242956A patent/AU2011242956B2/en not_active Ceased
- 2011-04-18 WO PCT/US2011/032822 patent/WO2011133442A1/en not_active Ceased
- 2011-04-18 NZ NZ602883A patent/NZ602883A/en not_active IP Right Cessation
- 2011-04-18 RU RU2012148908/04A patent/RU2012148908A/ru not_active Application Discontinuation
- 2011-04-18 CA CA2796437A patent/CA2796437C/en active Active
- 2011-04-18 ES ES11716155.4T patent/ES2610623T3/es active Active
- 2011-04-18 PL PL11716155T patent/PL2560956T3/pl unknown
- 2011-04-18 MX MX2012012092A patent/MX2012012092A/es active IP Right Grant
- 2011-04-18 JP JP2013506202A patent/JP2013525355A/ja active Pending
- 2011-04-18 EP EP11716155.4A patent/EP2560956B1/en active Active
- 2011-04-18 KR KR1020127030070A patent/KR101781665B1/ko not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525355A5 (cg-RX-API-DMAC7.html) | ||
| CA2796872A1 (en) | Novel synthesis for thiazolidinedione compounds | |
| US10442825B2 (en) | Method of hydrosilylation implementing an organic catalyst derived from germylene | |
| JP2010510976A5 (cg-RX-API-DMAC7.html) | ||
| JP2008511659A5 (cg-RX-API-DMAC7.html) | ||
| JP2012526842A5 (cg-RX-API-DMAC7.html) | ||
| RU2012138259A (ru) | Способ получения ривароксабана | |
| RU2013147400A (ru) | Способ получения производных кето-бензофурана | |
| JP2010530873A5 (cg-RX-API-DMAC7.html) | ||
| JP6938048B2 (ja) | オリゴシロキサン、及びシリルアセタールからのオリゴシロキサンの製造方法 | |
| RU2012148908A (ru) | Новый синтез соединений тиазолидиндиона | |
| JP2015514729A5 (cg-RX-API-DMAC7.html) | ||
| JP2010531855A5 (cg-RX-API-DMAC7.html) | ||
| JP6797268B2 (ja) | 新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法 | |
| KR101249361B1 (ko) | 고순도 트리스(트리알킬실릴)포스파이트의 제조 방법 | |
| EP2876111B1 (en) | Composition containing nitrogen-containing organoxysilane compound and method for making the same | |
| JP2014009330A5 (cg-RX-API-DMAC7.html) | ||
| JP2012530113A5 (cg-RX-API-DMAC7.html) | ||
| JP2004137258A5 (cg-RX-API-DMAC7.html) | ||
| JP2012006844A (ja) | アルコキシヒドロシランの製造方法 | |
| Schöpper et al. | Molecular structure of decamethylgermanocene in the solid state | |
| Singh et al. | Schiff bases of N-(2-aminoethyl)-3-aminopropyltrimethoxysilane and its silatranes: Synthesis and characterization | |
| WO2021085535A1 (ja) | 化合物及びその製造方法 | |
| Gholivand et al. | Phosphoramides bearing isoxazole derivative: spectroscopic and structural characterization, study of hydrogen-bonding interactions and two lanthanide complexes (LnIII= Ce and Eu) | |
| JP6842621B2 (ja) | 反応性置換基を有するシルセスキオキサンの製造方法 |